HU172032B - Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislot - Google Patents
Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislotInfo
- Publication number
- HU172032B HU172032B HU76IE00000737A HUIE000737A HU172032B HU 172032 B HU172032 B HU 172032B HU 76IE00000737 A HU76IE00000737 A HU 76IE00000737A HU IE000737 A HUIE000737 A HU IE000737A HU 172032 B HU172032 B HU 172032B
- Authority
- HU
- Hungary
- Prior art keywords
- poluchenija
- khinol
- alkankarbonovykh
- digidro
- okso
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB11644/75A GB1502312A (en) | 1975-03-20 | 1975-03-20 | Quinolone derivatives |
| GB4204375 | 1975-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU172032B true HU172032B (hu) | 1978-05-28 |
Family
ID=26248416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU76IE00000737A HU172032B (hu) | 1975-03-20 | 1976-03-19 | Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislot |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4066651A (OSRAM) |
| JP (1) | JPS51118773A (OSRAM) |
| AU (1) | AU1147676A (OSRAM) |
| CS (1) | CS188273B2 (OSRAM) |
| DD (1) | DD124117A5 (OSRAM) |
| DE (1) | DE2611824A1 (OSRAM) |
| DK (1) | DK115376A (OSRAM) |
| ES (1) | ES446234A1 (OSRAM) |
| FI (1) | FI760729A7 (OSRAM) |
| FR (1) | FR2304342A1 (OSRAM) |
| HU (1) | HU172032B (OSRAM) |
| IE (1) | IE43079B1 (OSRAM) |
| IL (1) | IL49126A0 (OSRAM) |
| LU (1) | LU74594A1 (OSRAM) |
| NL (1) | NL7602834A (OSRAM) |
| NO (1) | NO760993L (OSRAM) |
| PT (1) | PT64921B (OSRAM) |
| SE (1) | SE434394B (OSRAM) |
| SU (1) | SU648090A3 (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| US5225402A (en) * | 1989-02-10 | 1993-07-06 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| EP0382185B1 (en) * | 1989-02-10 | 1994-06-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| US5412104A (en) * | 1990-09-07 | 1995-05-02 | Schering Corporation | Ester and alkoxy substituted benzopyrans |
| TW198715B (OSRAM) * | 1991-04-19 | 1993-01-21 | Dtsuka Seiyaku Kk | |
| DK0543018T3 (da) * | 1991-06-07 | 1996-02-05 | Otsuka Pharma Co Ltd | Antidiabetikum |
| DE19839499A1 (de) * | 1998-08-29 | 2000-03-02 | Merck Patent Gmbh | 2-Oxo-2H-chinolinderivate |
| HUP0202814A3 (en) | 1999-08-27 | 2003-11-28 | Ligand Pharmaceuticals Inc San | Androgen receptor modulator compounds and methods for their preparation and pharmaceutical compositions containing them and their use |
| EP1212322A2 (en) | 1999-08-27 | 2002-06-12 | Ligand Pharmaceuticals Incorporated | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| WO2001019770A2 (en) | 1999-09-14 | 2001-03-22 | Ligand Pharmaceuticals Incorporated | Rxr modulators with improved pharmacologic profile |
| FR2811912B1 (fr) * | 2000-07-21 | 2003-02-07 | Gattefosse Ets Sa | Procede d'enrobage de particules solides par un agent thermofusible, et particules solides ainsi enrobees |
| BRPI0413820A (pt) * | 2003-08-22 | 2006-10-24 | Ligand Pharm Inc | derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio |
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| TWI417095B (zh) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途 |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) * | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| ATE496906T1 (de) | 2007-09-14 | 2011-02-15 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituierte 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-ä1,4'übipyri inyl-2'-one |
| ES2409215T3 (es) * | 2007-09-14 | 2013-06-25 | Janssen Pharmaceuticals, Inc. | 4-fenil-1H-piridin-2-onas 1-3-disustituidas |
| EA019085B1 (ru) | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны |
| WO2009062676A2 (en) * | 2007-11-14 | 2009-05-22 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| US20110236394A1 (en) * | 2007-11-15 | 2011-09-29 | Universite Laval | Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| WO2010025890A1 (en) | 2008-09-02 | 2010-03-11 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| EP2346505B1 (en) | 2008-10-16 | 2014-04-23 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| AU2009319387B2 (en) | 2008-11-28 | 2012-05-10 | Addex Pharma S.A. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| EA020672B1 (ru) | 2009-05-12 | 2014-12-30 | Янссен Фармасьютикалс, Инк. | Производные 1,2,4-триазоло[4,3-a]пиридина и их применение для лечения или предупреждения неврологических и психиатрических расстройств |
| NZ596053A (en) | 2009-05-12 | 2013-05-31 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| WO2012062751A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| CA2815002C (en) | 2010-11-08 | 2019-10-22 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| US9271967B2 (en) | 2010-11-08 | 2016-03-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| EP3424535A1 (en) | 2014-01-21 | 2019-01-09 | Janssen Pharmaceutica NV | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| IL279202B2 (en) | 2014-01-21 | 2023-09-01 | Janssen Pharmaceutica Nv | Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3772301A (en) * | 1971-11-22 | 1973-11-13 | Warner Lambert Co | (4-substituted)4-(methylsulfinyl)methylcarbostyrils |
-
1976
- 1976-02-23 IE IE352/76A patent/IE43079B1/en unknown
- 1976-02-25 SE SE7602339A patent/SE434394B/xx not_active IP Right Cessation
- 1976-02-27 AU AU11476/76A patent/AU1147676A/en not_active Expired
- 1976-03-01 IL IL49126A patent/IL49126A0/xx unknown
- 1976-03-01 US US05/662,685 patent/US4066651A/en not_active Expired - Lifetime
- 1976-03-17 DK DK115376A patent/DK115376A/da unknown
- 1976-03-18 LU LU74594A patent/LU74594A1/xx unknown
- 1976-03-18 DD DD191915A patent/DD124117A5/xx unknown
- 1976-03-18 NL NL7602834A patent/NL7602834A/xx not_active Application Discontinuation
- 1976-03-18 FI FI760729A patent/FI760729A7/fi not_active Application Discontinuation
- 1976-03-19 FR FR7608061A patent/FR2304342A1/fr active Granted
- 1976-03-19 CS CS761804A patent/CS188273B2/cs unknown
- 1976-03-19 NO NO760993A patent/NO760993L/no unknown
- 1976-03-19 SU SU762337250A patent/SU648090A3/ru active
- 1976-03-19 PT PT64921A patent/PT64921B/pt unknown
- 1976-03-19 DE DE19762611824 patent/DE2611824A1/de active Granted
- 1976-03-19 HU HU76IE00000737A patent/HU172032B/hu unknown
- 1976-03-20 ES ES446234A patent/ES446234A1/es not_active Expired
- 1976-03-22 JP JP51031184A patent/JPS51118773A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| AU1147676A (en) | 1977-09-01 |
| SE7602339L (sv) | 1976-09-21 |
| PT64921A (en) | 1976-04-01 |
| DD124117A5 (OSRAM) | 1977-02-02 |
| DE2611824C2 (OSRAM) | 1987-06-19 |
| NL7602834A (nl) | 1976-09-22 |
| IE43079L (en) | 1976-09-20 |
| FR2304342A1 (fr) | 1976-10-15 |
| ES446234A1 (es) | 1977-10-01 |
| SU648090A3 (ru) | 1979-02-15 |
| DK115376A (da) | 1976-09-21 |
| CS188273B2 (en) | 1979-02-28 |
| DE2611824A1 (de) | 1976-09-30 |
| IL49126A0 (en) | 1976-05-31 |
| JPH0122267B2 (OSRAM) | 1989-04-25 |
| US4066651A (en) | 1978-01-03 |
| FR2304342B1 (OSRAM) | 1979-09-21 |
| JPS51118773A (en) | 1976-10-18 |
| LU74594A1 (OSRAM) | 1977-05-06 |
| SE434394B (sv) | 1984-07-23 |
| NO760993L (OSRAM) | 1976-09-21 |
| FI760729A7 (OSRAM) | 1976-09-21 |
| PT64921B (en) | 1977-08-24 |
| IE43079B1 (en) | 1980-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU172032B (hu) | Sposob poluchenija al'fa-/1-aril-1,2-digidro-2-okso-khinol-4-il/-alkankarbonovykh kislot | |
| HU171717B (hu) | Sposob poluchenija slozhnykh alkil'nykh ehfirov 1,4-digidropiridin-karbonovoj kisloty i lechebnykh preparatov soderzhahhikh takie soedinenija | |
| HU174805B (hu) | Sposob poluchenija katalizatorov dlja polimerizacii al'fa-olefinov | |
| HU175109B (hu) | Sposob poluchenija novykh benzgidril-sul'finilovykh proizvodnykh | |
| FR2312248A1 (fr) | 1,3,-dihydroimidazo 4,5,-b pyridin-2-ones | |
| SE7604095L (sv) | 4,4-dihydrospiro-2h-1,3-bensoxaziner | |
| BE847073A (fr) | 1,4-bis-(azolyl-(2'))-naphtalenes, | |
| HU173579B (hu) | Sposob poluchenija asimmetricheskikh 1,3-dvoe-zamehhennykh nitrozo-mochevin | |
| SE7609769L (sv) | 1,2-bensisoxazolderivat | |
| BE856409A (fr) | 2,6-methano-2h-1-benzoxocines | |
| FR2297628A1 (fr) | 2,3-dihydroergolines | |
| NL7607985A (nl) | 12-alkoxy-3,7,11-trimethyldodecatetraenen. | |
| HU172460B (hu) | Sposob poluchenija novykh proizvodnykh 5,6-digidro-3h-pirimidin-4-ona | |
| FR2314732A1 (fr) | Solution d'iodophore | |
| HU173879B (hu) | Sposob poluchenija proizvodnykh tetrazolil- i tetrazolilalkil-imidazola i benzimidazola i farmacepticheskikh preparatov, soderzhahhikh ehti soedinenija v kachestve aktivnykh vehhestv | |
| FI773466A7 (fi) | Substituerade 2,1,3-bentsotiadiazinfoereningar | |
| BE854184A (fr) | 1,2,6-thiadiazinones | |
| SE7608452L (sv) | 2,4-diamino-5-benzylpyrimidiner | |
| HU173708B (hu) | Sposob poluchenija geterokolloidnogo 18-arabinozil-2-n-butil-3,7,11,15,19,21,23,27,25,37-dekagidroksi-4,16,32,34,36-pentametil-tetrakona-16,32-dien-35-0-lakton-40-guanidiniumsul'fata | |
| SE7608417L (sv) | 2-klor-n-isopropyl-2',3'-dimetylacetanilid | |
| HU174538B (hu) | Sposob poluchenija proizvodnykh 4,4-dimetil-pirrolidin-3,5-diona | |
| BE847341A (fr) | N-(3,5-dihalogenophenyl) cyclopropanedicar-boximides, | |
| BE844697A (fr) | Ar-octahalodiphenyl-ether-4,4'-dimethanol | |
| HU173509B (hu) | Sposob poluchenija proizvodnykh 1,2-benzo-tiazin-3-karboksamida | |
| HU174020B (hu) | Sposob poluchenija proizvodnykh 1,4-benzodiazepina, zamehhennykh v pozicii 2 |